Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02018692 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2027 to Dec 31, 2028
    • Start date: Mar 1, 2025 to Mar 1, 2026
    v10
  2. Primary and study completion dates: Dec 31, 2026 to Dec 31, 2027
    • Start date: Mar 1, 2024 to Mar 1, 2025
    v9
  3. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2026
    • Start date: Mar 1, 2021 to Mar 1, 2024
    v8
  4. Start date: Dec 1, 2019 to Mar 1, 2021v7
  5. Primary and study completion dates: Dec 31, 2019 to Dec 31, 2022
    • Start date: Jan 1, 2018 to Dec 1, 2019
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Jun 2019 to Dec 31, 2019
    • Start date: Jun 2017 to Jan 1, 2018
    • Study completion date: Dec 31, 2019
    v5
  2. Primary completion date: Jun 2016 to Jun 2019
    • Start date: Dec 2015 to Jun 2017
    v4
  3. Start date: Jul 2015 to Dec 2015v3
  4. Primary completion date: Dec 2015 to Jun 2016
    • Start date: Jul 2015
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to determine whether 9-cis-beta Caroten rich D. Brdawiil extract is effective in the treatment of retinitis pigmentosa in adolescent patients.
Trial Details
NCT Number NCT02018692
Lead Sponsor Sheba Medical Center
Conditions
(from sponsor)		 Retinitis Pigmentosa
Related terms Retinitis Pigmentosa
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov